Intact Investment Management Inc. acquired a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 460 shares of the company’s stock, valued at approximately $75,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Innealta Capital LLC bought a new stake in shares of Clorox during the second quarter valued at approximately $30,000. Trifecta Capital Advisors LLC raised its stake in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. First Foundation Advisors acquired a new position in Clorox during the 1st quarter worth $31,000. Family Firm Inc. bought a new position in shares of Clorox in the second quarter worth $31,000. Finally, Quarry LP increased its holdings in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. 78.53% of the stock is currently owned by institutional investors.
Insider Activity at Clorox
In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.57% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Research Report on Clorox
Clorox Trading Down 0.1 %
Clorox stock opened at $162.37 on Wednesday. The company has a 50 day moving average price of $161.75 and a 200 day moving average price of $146.46. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The Clorox Company has a 52 week low of $125.46 and a 52 week high of $169.09. The firm has a market capitalization of $20.10 billion, a price-to-earnings ratio of 56.57, a P/E/G ratio of 3.11 and a beta of 0.41.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. Clorox’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 earnings per share. Research analysts forecast that The Clorox Company will post 6.81 EPS for the current year.
Clorox Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.01%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 170.03%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- What Are the FAANG Stocks and Are They Good Investments?
- Palantir Cracks $50, Is There Still Time to Get on Board?
- How to Use the MarketBeat Excel Dividend Calculator
- Insider Buying Signals Upside for These 3 Stocks
- What Investors Need to Know to Beat the Market
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.